Redmile Group, LLC - 30 Jun 2025 SCHEDULE 13G/A Report for Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share (STOK)

Filing Manager
Redmile Group, LLC
Reporting Manager
Redmile Group, LLC
Security
Stoke Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
STOK
Shares outstanding
54,699,138 shares
Disclosed Ownership
4,375,931 shares
Ownership
8%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 16:19:42 UTC
Date of event
30 Jun 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Redmile Group, LLC 8% 4,375,931 0 4,375,931 /s/ Jeremy C. Green Managing Member
Jeremy C. Green 8% 4,375,931 0 4,375,931 /s/ Jeremy C. Green Jeremy C. Green
Redmile Biopharma Investments III, L.P. 6.4% 3,505,612 0 3,505,612 /s/ Jeremy C. Green Managing Member of Redmile Biopharma Investments III (GP), LLC, general partner of Redmile Biopharma Investments III, L.P.